Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-003671
Filing Date
2025-08-20
Accepted
2025-08-20 10:05:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8866
  Complete submission text file 0001172661-25-003671.txt   10711
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY Canada (Federal Level)
Business Address 919 11 AVENUE SW SUITE 300 CALGARY Canada (Federal Level) 14039485227
SNDL Inc. (Subject) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91442 | Film No.: 251234427
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)